CAMP
HEALTHCARECAMP4 Therapeutics Corp
$4.06+0.08 (+2.01%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CAMP Today?
No stock-specific AI insight has been generated for CAMP yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.31$7.75
$4.06
Fundamentals
Market Cap$211M
P/E Ratio—
EPS$-2.65
Dividend Yield—
Dividend / Share—
ROE-1.5%
Profit Margin—
Debt / Equity—
Trading
Volume32K
Avg Volume (10D)—
Shares Outstanding51.9M
CAMP News
20 articles- CAMP4 Therapeutics Corporation (CAMP) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 7, 2026
- CAMP4 Reports First Quarter 2026 Financial Results and Corporate HighlightsYahoo Finance·May 7, 2026
- CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene UpregulationYahoo Finance·Apr 28, 2026
- CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·Apr 17, 2026
- CAMP4 Therapeutics Unveils Gene-Upregulation ASO Platform, Targets SYNGAP1 Clinic Entry in 2HMarketbeat·Apr 13, 2026
- CAMP4 Appoints Michael MacLean to its Board of DirectorsYahoo Finance·Mar 24, 2026
- Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million ExitMotley Fool·Mar 18, 2026
- Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million ExitMotley Fool·Mar 18, 2026
- Biotech Alert: Searches spiking for these stocks todayYahoo Finance·Mar 12, 2026
- CAMP4 to Participate in Upcoming Investor ConferencesYahoo Finance·Mar 6, 2026
- CAMP4 Reports Full Year 2025 Financial Results and Corporate HighlightsYahoo Finance·Mar 5, 2026
- CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·Feb 20, 2026
- CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's WhyYahoo Finance·Jan 13, 2026
- CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare ConferenceYahoo Finance·Jan 6, 2026
- Novo files for CagriSema approval; Merck and Pfizer’s trial winBiopharmadive·Dec 19, 2025
- CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common StockYahoo Finance·Dec 18, 2025
- CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic DiscoveriesYahoo Finance·Dec 18, 2025
- Positive week for Camp4 Therapeutics Corporation (NASDAQ:CAMP) institutional investors who lost 46% over the past yearYahoo Finance·Dec 10, 2025
- CAMP4 Reports Third Quarter 2025 Financial Results and Corporate HighlightsYahoo Finance·Nov 6, 2025
- CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01Yahoo Finance·Oct 1, 2025
All 20 articles loaded
Price Data
Open$3.90
Previous Close$3.98
Day High$4.21
Day Low$3.80
52 Week High$7.75
52 Week Low$1.31
52-Week Range
$1.31$7.75
$4.06
Fundamentals
Market Cap$211M
P/E Ratio—
EPS$-2.65
Dividend Yield—
Dividend / Share—
ROE-1.5%
Profit Margin—
Debt / Equity—
Trading
Volume32K
Avg Volume (10D)—
Shares Outstanding51.9M
About CAMP4 Therapeutics Corp
CalAmp Corp. The company is headquartered in Irvine, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—